Business Description
Parmax Pharma Ltd
ISIN : INE240T01014
Compare
Compare
Traded in other countries / regions
540359.India IPO Date
2017-03-16Description
Parmax Pharma Ltd is a pharmaceutical company. The company manufactures and sells Tablets, Capsules, Ointments, and Injectable. Its products include Aripiprazole, Lamotrigine I.P., Nebivolol Hydrochloride, Indapamine USP, Voglibos, Paliperidone, Lacosamide, 2-Acetyl Benzo(B) Thiophene, Camphor Sulfonyl Chloride, 3-Methoxy Thiophene, Silodosin API, and others.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | 0.01 | |||||
| Debt-to-Equity | 56.09 | |||||
| Debt-to-EBITDA | -1.78 | |||||
| Piotroski F-Score | 1/9 | |||||
| Altman Z-Score | -0.19 | |||||
| Beneish M-Score | -3.65 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -25 | |||||
| 3-Year Book Growth Rate | -73.8 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.14 | |||||
| 9-Day RSI | 43.34 | |||||
| 14-Day RSI | 45.3 | |||||
| 6-1 Month Momentum % | -9.55 | |||||
| 12-1 Month Momentum % | -2.07 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.63 | |||||
| Quick Ratio | 0.37 | |||||
| Cash Ratio | 0.01 | |||||
| Days Inventory | 156.81 | |||||
| Days Sales Outstanding | 51.3 | |||||
| Days Payable | 292.07 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -1.96 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 36.2 | |||||
| Operating Margin % | -45.09 | |||||
| Net Margin % | -52.03 | |||||
| FCF Margin % | -16.13 | |||||
| ROE % | -188.61 | |||||
| ROA % | -35.66 | |||||
| ROIC % | -43.18 | |||||
| ROC (Joel Greenblatt) % | -53.96 | |||||
| ROCE % | -59.44 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.11 | |||||
| PB Ratio | 117.67 | |||||
| Price-to-Tangible-Book | 115.46 | |||||
| EV-to-EBIT | -3.56 | |||||
| EV-to-EBITDA | -5.41 | |||||
| EV-to-Revenue | 1.62 | |||||
| EV-to-FCF | -9.61 | |||||
| Earnings Yield (Greenblatt) % | -28.08 | |||||
| FCF Yield % | -14.74 | |||||
| Forward Rate of Return (Yacktman) % | 14.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Parmax Pharma Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 110.53 | ||
| EPS (TTM) (₹) | -15.37 | ||
| Beta | 0.25 | ||
| Volatility % | 21.55 | ||
| 14-Day RSI | 45.3 | ||
| 14-Day ATR (₹) | 2.152049 | ||
| 20-Day SMA (₹) | 30.0285 | ||
| 12-1 Month Momentum % | -2.07 | ||
| 52-Week Range (₹) | 24.18 - 37.9 | ||
| Shares Outstanding (Mil) | 3.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Parmax Pharma Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Parmax Pharma Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Parmax Pharma Ltd Frequently Asked Questions
What is Parmax Pharma Ltd(BOM:540359)'s stock price today?
The current price of BOM:540359 is ₹32.33. The 52 week high of BOM:540359 is ₹37.90 and 52 week low is ₹24.18.
When is next earnings date of Parmax Pharma Ltd(BOM:540359)?
The next earnings date of Parmax Pharma Ltd(BOM:540359) is .
Does Parmax Pharma Ltd(BOM:540359) pay dividends? If so, how much?
Parmax Pharma Ltd(BOM:540359) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers